| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 08/16/2001 | EP1143946A3 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 08/16/2001 | EP1123393A1 Follistatin-related protein zfsta2 |
| 08/16/2001 | EP1123315A1 Multiple domain glycoprotein hormones and methods of using |
| 08/16/2001 | EP1123296A1 PYRAZOLOPYRIMIDINONE cGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL DYSFUNCTION |
| 08/16/2001 | EP1123292A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123279A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123269A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123268A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123267A1 New compounds, their preparation and use |
| 08/16/2001 | EP1123091A1 Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| 08/16/2001 | EP1123088A1 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
| 08/16/2001 | EP1123085A1 O/w emulsion comprising an hydroxylated oil |
| 08/16/2001 | EP0891345B1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
| 08/16/2001 | CA2800450A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/16/2001 | CA2399873A1 Drug metabolizing enzymes |
| 08/16/2001 | CA2399821A1 Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof |
| 08/16/2001 | CA2399421A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399148A1 Antibodies that bind human interleukin-18 and methods of making and using |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/15/2001 | CN1308536A Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 08/15/2001 | CN1308531A Vitamin E and esters thereof for use in the topical treatment of mucosal pathologies |
| 08/15/2001 | CN1308528A Plaster which contains steroids, and method for the production and use thereof |
| 08/15/2001 | CN1307879A Chinese medicine for treating male veneral disease |
| 08/15/2001 | CN1307873A Coated Gongyanping tablet in special shape and its making process |
| 08/15/2001 | CN1069522C Transdermal presentation of nitroglycerin for preventing undesired uterine contraction |
| 08/15/2001 | CN1069521C Improvement of auxiliary material containing chlorohaxanpyridine acetate |
| 08/14/2001 | US6274619 Amidino substituted tetrahydrobenzo thiophene or furan derivatives and their use as urokinase inhibitors |
| 08/14/2001 | US6274618 Administering (-)-cis-6-phenyl-5-(4-(2-pyrrolidin-1-yl-ethoxy)-phenyl)-5,6,7,8 -tetrahydronphthalen-2-ol to treat vaginal dryness, itching, or painful intercourse |
| 08/14/2001 | US6274587 Tricyclic dihydropyrimidine potassium channel openers |
| 08/14/2001 | US6274583 Alpha 1a adrenergic receptor antagonists |
| 08/14/2001 | US6274579 Pharmaceutically active morpholinol |
| 08/14/2001 | CA2088778C Transdermal contraceptive formulations, methods and devices |
| 08/09/2001 | WO2001057022A2 Pyrazole compositions useful as inhibitors of erk |
| 08/09/2001 | WO2001057008A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | WO2001057002A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | WO2001056598A2 Methods for preventing or attenuating pathoangiogenic conditions by using gbs-toxin (cm101) |
| 08/09/2001 | WO2001019814A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 08/09/2001 | WO2001018004A3 PYRAZOLO[4,3-d]PYRIMIDINES |
| 08/09/2001 | WO2001002006A3 Fertility impairing vaccine containing avian zona pellucida protein and method of use |
| 08/09/2001 | WO2000069257A3 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 08/09/2001 | WO2000066094A3 Use of compounds with a nitrogen-oxygen heterocycle as anti-infectious agents |
| 08/09/2001 | US20010012845 Adminstering an E-type prostaglandin ligand and a cyclooxygenase-2 enzyme selective inhibitor compound in combination with a carrier to treat inflammation |
| 08/09/2001 | CA2398754A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors |
| 08/09/2001 | CA2398674A1 Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same |
| 08/09/2001 | CA2369050A1 Methods for preventing or attenuating pathoangiogenic conditions |
| 08/08/2001 | EP1122243A1 Novel imidazoles with anti-inflammatory activity |
| 08/08/2001 | EP1121444A2 Protein kinase homologs |
| 08/08/2001 | EP1121375A1 High purity composition comprising (7alpha,17alpha)- 17-hydroxy- 7-methyl- 19-nor-17-pregn- 5(10)-en-20-yn-3-one |
| 08/08/2001 | EP1121372A1 Adenine derivatives |
| 08/08/2001 | EP1121115A1 Pufa supplements |
| 08/08/2001 | EP1121108A2 Novel therapeutic use of compounds with beta-3-agonist activity |
| 08/08/2001 | EP1121100A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 08/08/2001 | CN1307643A Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 08/08/2001 | CN1307636A Endometriosis-associated gene |
| 08/08/2001 | CN1307584A Macrolide LHRH antagonists |
| 08/08/2001 | CN1307574A Indolyl derivatives as serotonergic agents |
| 08/08/2001 | CN1307481A Methods for treating hot flashes and gynaecomastia |
| 08/08/2001 | CN1307480A Fertility improving composition and application thereof |
| 08/08/2001 | CN1307472A Compositions comprising organic mono-or dinitrate for treating impotence |
| 08/08/2001 | CN1306853A Pregnancy promoting medicine for treating hyperprolactinemia sterility and its preparation |
| 08/08/2001 | CN1306849A Chinese medicine composition for sterility |
| 08/08/2001 | CN1306831A Medicine for diabetic to restore sexual function |
| 08/08/2001 | CN1306820A Phentolaminum capsule and its preparation |
| 08/08/2001 | CN1069318C Cyclic gmp-specific phosphodiesterase inhibitors |
| 08/08/2001 | CN1069317C Novel indane-2-mercaptoacetamide disulfide derivs, useful as inhibitors of enkephaliinase |
| 08/08/2001 | CN1069312C Substituted imidogen sulfamide, its preparation, use and medicines containing the same |
| 08/08/2001 | CN1069214C Stabilized somatotropin for parenteral administration |
| 08/08/2001 | CN1069202C Leigongma liquor and its prepn. method |
| 08/07/2001 | US6271248 Substituted biphenysulfonamide endothelin antagonists |
| 08/07/2001 | US6271201 Methods for the selective regulation of placental prostanoids and inhibition of labor using IGF-I |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | CA2015296C Pyranyl cyanoguanidine derivatives |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055392A2 Nuclear hormone receptors |
| 08/02/2001 | WO2001055356A2 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | WO2001055337A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | WO2001055219A2 scsCNTFR/NNT-1 FUSION PROTEIN |
| 08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | WO2001055172A2 ISOLATED COMPLEX COMPRISING A NNT-1 PROTEIN AND IN ADDITION AT LEAST A CLF-1 PROTEIN AND/OR A sCNTFRα PROTEIN |
| 08/02/2001 | WO2001055152A1 BENZOXATHIEPINO[3,4-b]PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS |
| 08/02/2001 | WO2001055134A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vassopressin receptors |
| 08/02/2001 | WO2001055132A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 08/02/2001 | WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 08/02/2001 | WO2001055119A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 08/02/2001 | WO2001055115A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/02/2001 | WO2001055112A1 Method for preparing alpha-sulfonyl hydroxamic acid derivatives |
| 08/02/2001 | WO2001055106A2 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | WO2001054731A2 Ligand conjugates and methods for preparing same |
| 08/02/2001 | WO2001054715A1 Use of fsh for treating infertility |
| 08/02/2001 | WO2001054700A1 Pharmaceutical preparation and method for treatment of diabetes |
| 08/02/2001 | WO2001013932A3 Stimulation of sperm function |
| 08/02/2001 | WO2000066564A8 Benzimidazolones and analogues and their use as progesterone receptor ligands |
| 08/02/2001 | WO2000066175A3 Conjugates as therapies for cancer and prostate diseases |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010011093 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | CA2398728A1 Novel melanocortin receptor agonists and antagonists |
| 08/02/2001 | CA2398615A1 Benzoxathiepino[3,4-b]pyridine derivatives, process for their preparation and their use as medicaments |
| 08/02/2001 | CA2398564A1 Nuclear hormone receptors |